Home

Headache

Read time: 3 min

Uncovering dopamine deficits in schizophrenia through advanced imaging

Neuroimaging tools offer invaluable perspectives on the neurochemistry and function of the brain in...

Read time: 3 min

Psychiatry benefits from neuropsychopharmacology knowledge

Progress in psychiatric research is moving at a new and unprecedented pace, which makes...

Read time: 5 min

Circuit breakers – and why imaging studies are crucial to drug development

Depression is no longer the sole province of serotonin-based research. Imaging studies have...

Read time: 4 min

Nurture and networks – supporting the next generation of scientists and psychiatrists

Young scientists, brimming with ideas and eager to progress, are vital for the future of psychiatry...

Alzheimer's Disease

Read time: 5 min

Congress highlights

Alzheimer’s Disease: ethics of early diagnosis and practicalities of prevention

Drugs for Alzheimer’s have not been conspicuously successful. Do we need to think more about...

Alzheimer's Disease

Read time: 3 min

Diagnosing and treating Alzheimer’s Disease: an interview with Professor Jakub Hort, Prague, Czech Republic*

Alzheimer's Disease, Parkinson's Disease

Read time: 3 min

Congress highlights

Highlights from the neurodegenerative disease sessions

Primary progressive aphasia, amyloid PET in Alzheimer’s diagnosis, treating Parkinson’s...

Alzheimer's Disease

Read time: 3 min

Congress highlights

Time for sleep to take the stage?

Sleep disruption is a major consequence of Alzheimer’s Disease. Could it also help cause the...

Parkinson's Disease

Read time: 2 min

Congress highlights

Neglected problems of speech and swallowing respond to integrated management

Speech problems can appear before classical Parkinsonian symptoms and are a sensitive marker of...

Parkinson's Disease

Read time: 4 min

Congress highlights

Biomarkers chart path from prodrome to Parkinson’s Disease

Reliable biomarkers of high risk would open up the prospect of preventing Parkinson’s Disease...

Alzheimer's Disease

Read time: 4 min

Congress highlights

A clearer picture of trouble ahead: neuroimaging in patients with dementia and those at risk

Brain loss, amyloid and tau: imaging can detect in vivo all three hallmarks of Alzheimer’s...

Parkinson's Disease

Read time: 5 min

Congress highlights

Quality of life, quality of care: shared perspectives in Parkinson’s Disease

For both practical and ethical reasons, managing chronic conditions such as Parkinson’s...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country